Published in Antimicrob Agents Chemother on January 01, 1999
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrob Agents Chemother (2002) 1.46
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob Agents Chemother (2001) 1.20
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages. Antimicrob Agents Chemother (2005) 1.20
Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts. J Dent Res (2002) 1.02
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection. Antimicrob Agents Chemother (2010) 1.01
Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model. Antimicrob Agents Chemother (2002) 0.94
An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells. J Periodontol (2002) 0.91
Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Antimicrob Agents Chemother (2001) 0.88
Intracellular penetration and activity of gemifloxacin in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (2000) 0.83
Activities of antimicrobial agents against intracellular pneumococci. Antimicrob Agents Chemother (2000) 0.81
Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort. Eur J Clin Pharmacol (2010) 0.80
Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. Antimicrob Agents Chemother (2005) 0.80
Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae. Wien Klin Wochenschr (2007) 0.79
Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose. Antimicrob Agents Chemother (2004) 0.79
Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice. Antimicrob Agents Chemother (2005) 0.77
A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid. J Clin Microbiol (2016) 0.75
Intracellular penetration and activity of DX-619 in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (2006) 0.75
Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging. Sci Rep (2016) 0.75
In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob Agents Chemother (1997) 3.22
Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. J Infect Dis (1977) 3.09
In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy (1997) 2.82
Clindamycin uptake by human neutrophils. J Infect Dis (1981) 2.49
Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1989) 1.69
Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Am J Med (1984) 1.64
Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages. Antimicrob Agents Chemother (1994) 1.60
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans. Antimicrob Agents Chemother (1997) 1.57
Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. Eur J Clin Microbiol (1987) 1.55
Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells. Antimicrob Agents Chemother (1990) 1.51
Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells. Antimicrob Agents Chemother (1992) 1.37
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Antimicrob Agents Chemother (1997) 1.22
Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrob Agents Chemother (1997) 1.15
Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1994) 1.07
Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells. Diagn Microbiol Infect Dis (1992) 0.98
Susceptibility of Chlamydia trachomatis to trovafloxacin. J Antimicrob Chemother (1997) 0.88
Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages. Zentralbl Bakteriol (1997) 0.83
Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med (2001) 4.75
Activities of new quinoline derivatives against genital pathogens. Antimicrob Agents Chemother (1985) 2.51
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1980) 2.47
Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. J Antimicrob Chemother (2003) 2.37
Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol (2001) 2.06
[Clinical microbiology: a specialty in crisis?]. Enferm Infecc Microbiol Clin (1998) 1.98
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria. Antimicrob Agents Chemother (1984) 1.77
Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1989) 1.69
Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry (2009) 1.67
Virtual slide telepathology systems with JPEG2000. Conf Proc IEEE Eng Med Biol Soc (2007) 1.51
Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells. Antimicrob Agents Chemother (1990) 1.51
Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol (1992) 1.42
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40
[Usefulness of the disk diffusion method for evaluating the sensitivity of Neisseria meningitidis to penicillin and cefotaxime]. Enferm Infecc Microbiol Clin (1997) 1.39
[Migraine and MIDAS (MIDASELA) in Colombian hospital workers]. Rev Neurol (2003) 1.39
Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells. Antimicrob Agents Chemother (1992) 1.37
Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J Antimicrob Chemother (2008) 1.36
Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles. Antimicrob Agents Chemother (2000) 1.32
Cefoxitin sodium activity against anaerobes: effect of the inoculum size, pH variation and different culture media. J Antimicrob Chemother (1978) 1.32
Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother (2007) 1.31
Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect (2007) 1.28
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood (2001) 1.26
Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains. Antimicrob Agents Chemother (1998) 1.23
Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res (1998) 1.21
Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea. Sex Transm Dis (1986) 1.21
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother (1999) 1.20
Decrease in phytochrome pelletability induced by green + far-red light in Trifolium repens. Biochem Biophys Res Commun (1981) 1.16
Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. Clin Microbiol Infect (2006) 1.16
Soil pollution by a pyrite mine spill in Spain: evolution in time. Environ Pollut (2004) 1.15
Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrob Agents Chemother (1997) 1.15
Comparative in vitro activities of new quinolones against coryneform bacteria. Antimicrob Agents Chemother (1994) 1.15
Primary structure and expression pattern of the 33-kDa chitinase gene from the mycoparasitic fungus Trichoderma harzianum. Curr Genet (1995) 1.09
Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1994) 1.07
NGFI-A gene expression is necessary for T lymphocyte proliferation. J Biol Chem (1993) 1.07
Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1. Clin Microbiol Infect (2008) 1.06
HIV-1 infected patients older than 50 years. PISCIS cohort study. J Infect (2008) 1.04
Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts. J Biol Chem (1999) 1.04
Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology (1997) 1.03
Pollution of soils by the toxic spill of a pyrite mine (Aznalcollar, Spain). Sci Total Environ (1999) 1.02
L-usnate-urease interactions: binding sites for the ligand. Z Naturforsch C (1981) 1.02
Kinetics of adherence of mucoid and non-mucoid Pseudomonas aeruginosa to plastic catheters. J Med Microbiol (1991) 1.01
N-formimidoyl-thienamycin activity against anaerobes: effect of the inoculum, pH and culture media. J Antimicrob Chemother (1981) 0.99
Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells. Diagn Microbiol Infect Dis (1992) 0.98
Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella. Antimicrob Agents Chemother (1978) 0.98
Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1993) 0.97
Comparison of broth microdilution and E-test for susceptibility testing of Neisseria meningitidis. J Clin Microbiol (1996) 0.96
Oral sex as a risk factor for Chlamydia-negative ureaplasma-negative nongonococcal urethritis. Sex Transm Dis (1988) 0.96
In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria. Antimicrob Agents Chemother (1998) 0.96
Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem (2000) 0.94
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa. J Antimicrob Chemother (1980) 0.92
Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction. J Proteomics (2012) 0.92
Comparative penetration of lomefloxacin and other quinolones into human phagocytes. Am J Med (1992) 0.92
Single doses of ofloxacin in uncomplicated gonorrhoea. Drugs (1987) 0.92
Antibiotic resistance, plasmid profile, auxotypes and serovars of Neisseria gonorrhoeae strains isolated in Sevilla (Spain). Genitourin Med (1990) 0.92
Azithromycin uptake by tissue cultured epithelial cells. J Antimicrob Chemother (1997) 0.91
In vitro adherence of Enterococcus faecalis and Enterococcus faecium to urinary catheters. Eur J Clin Microbiol Infect Dis (2000) 0.91
Comparative activities of eight quinolones against members of the Bacteroides fragilis group. Antimicrob Agents Chemother (1994) 0.91
Effect of three plastic catheters on survival and growth of Pseudomonas aeruginosa. J Hosp Infect (1990) 0.90
Endovascular repair of a ruptured giant popliteal artery aneurysm. Ann Vasc Surg (2008) 0.90
In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenes. J Antimicrob Chemother (1999) 0.90
De novo tumors after orthotopic liver transplantation. Transplant Proc (2002) 0.90
Trends in the susceptibilities of Proteus mirabilis isolates to quinolones. J Antimicrob Chemother (2000) 0.89
Vectorization with SIMD extensions speeds up reconstruction in electron tomography. J Struct Biol (2010) 0.89
Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells. Int J Antimicrob Agents (2000) 0.89
Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points. J Eur Acad Dermatol Venereol (2013) 0.89
Interaction of limestone grains and acidic solutions from the oxidation of pyrite tailings. Environ Pollut (2005) 0.89
Soil pollution by oxidation of tailings from toxic spill of a pyrite mine. Sci Total Environ (2001) 0.89
Resistance of Pseudomonas aeruginosa to imipenem induced by eluates from siliconized latex urinary catheters is related to outer membrane protein alterations. Antimicrob Agents Chemother (1999) 0.88
Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria. Antimicrob Agents Chemother (1986) 0.88
Factors affecting the intracellular accumulation and activity of azithromycin. J Antimicrob Chemother (1995) 0.88
Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc (2005) 0.88
Ambient trace element background concentrations in soils and their use in risk assessment. Sci Total Environ (2009) 0.88
Choledochocholedochostomy conversion to hepaticojejunostomy due to biliary obstruction in liver transplantation. World J Surg (2001) 0.87
Exploiting desktop supercomputing for three-dimensional electron microscopy reconstructions using ART with blobs. J Struct Biol (2008) 0.87
Long-term biliary complications after liver surgery leading to liver transplantation. World J Surg (2001) 0.87
Effect of plastic catheter material on bacterial adherence and viability. J Med Microbiol (1991) 0.87
Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis. J Hosp Infect (1993) 0.86
Activity of eight antibacterial agents on Staphylococcus epidermidis attached to Teflon catheters. J Med Microbiol (1994) 0.86
Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci. Chemotherapy (1989) 0.86
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides. J Antimicrob Chemother (1984) 0.86
[Enterobacter cloacae bacteremia in dialysis patients]. Rev Clin Esp (1975) 0.86
Phosphonomycin (MK-955). Quantitative sensitivity spectra of various hospital strains to this new antibiotic. Microbiol Esp (1972) 0.86
Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin. Transplant Proc (1999) 0.85
Effect of a siliconized latex urinary catheter on bacterial adherence and human neutrophil activity. Diagn Microbiol Infect Dis (1991) 0.85
Seeds of Thevetia species as an alternative source of digitoxigenin. J Org Chem (1977) 0.85
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. J Antimicrob Chemother (1996) 0.85
Susceptibility to antimicrobial agents of Pseudomonas aeruginosa attached to siliconized latex urinary catheters. Eur J Clin Microbiol Infect Dis (1993) 0.85
Risk factors of graft loss in orthotopic liver transplantation. Transplant Proc (1998) 0.84
Bone mineral density and androgen levels in elderly males. Calcif Tissue Int (1999) 0.84
Hepatic cirrhosis with sarcoid granulomas. Differential diagnosis and liver transplantation: a case report. Transplant Proc (2003) 0.84
Tumor necrosis factor-alpha increases ATP content in metabolically inhibited L929 cells preceding cell death. J Biol Chem (1997) 0.84